Shuwei Weng
Shuwei Weng publishes mostly in Epidemiology, Endocrinology, Diabetes and Metabolism and Immunology, on topics such as Liver Disease Diagnosis and Treatment, Lipoproteins and Cardiovascular Health and Diabetes, Cardiovascular Risks, and Lipoproteins.
- World rank
- #1,620,545 of 7,710,434 ranked researchers
- Rank in China
- #244,123 of 978,568
- Works
- 32
- Citations
- 278
- Citations per work
- 8.7
What does Shuwei Weng research?
Shuwei Weng's work is mostly in Medicine (34%), Immunology and Microbiology (7%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1752.2%
- Health Sciences1134.0%
- Medicine1134.0%
- Life Sciences413.8%
- 1Epidemiology12% of their works
- 2Endocrinology, Diabetes and Metabolism8% of their works
- 3Immunology7% of their works
- 4Surgery7% of their works
- 5Cardiology and Cardiovascular Medicine6% of their works
- 6Molecular Biology6% of their works
Research topics
- Liver Disease Diagnosis and Treatment
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Adipokines, Inflammation, and Metabolic Diseases
- Inflammatory Biomarkers in Disease Prognosis
- Genetic Associations and Epidemiology
- Metabolism, Diabetes, and Cancer
- Biomarkers in Disease Mechanisms
Which keywords describe Shuwei Weng's research?
The keywords of their largest research topics: Insulin Resistance, Metabolic Syndrome, Cardiovascular Disease, Inflammation, C-Reactive Protein, Obesity, Cancer and NAFLD.
- Metformin
- Genome-Wide Association
- AMP-Activated Protein Kinase
- Immunity
- Diabetes
- Adipokines
- Cholesterol-lowering
- NAFLD
- Obesity
- Inflammation
- Metabolic Syndrome
- Insulin Resistance
- Cardiovascular Disease
- C-Reactive Protein
- Cancer
- NASH
- Statins
- Adipose Tissue
- Glucose Metabolism
- Neutrophil-to-Lymphocyte Ratio
- Genetic Variation
- Innate Immunity
- Pentraxins
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Insulin Resistance143 topics
- Metabolic Syndrome143 topics
- Cardiovascular Disease103 topics
- Inflammation103 topics
- C-Reactive Protein92 topics
- Obesity82 topics
- Cancer62 topics
- NAFLD61 topic
- NASH61 topic
- Cholesterol-lowering51 topic
- Statins51 topic
- Adipokines41 topic
- Adipose Tissue41 topic
- Diabetes41 topic
- Glucose Metabolism41 topic
- Immunity41 topic
- Neutrophil-to-Lymphocyte Ratio41 topic
- AMP-Activated Protein Kinase21 topic
- Genetic Variation21 topic
- Genome-Wide Association21 topic
- Innate Immunity21 topic
- Metformin21 topic
- Pentraxins21 topic
Where does Shuwei Weng work?
Shuwei Weng's main affiliation in the publication record is Central South University, China.
How many publications and citations does Shuwei Weng have?
OpenAlex counts 32 works and 278 citations for Shuwei Weng, an h-index of 11, ranking #1,620,545 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shuwei Weng. Posts are plain text and can be reported.